2024-01-01 2024-12-31 false Capium Accounts Production 1.1 05835926 2024-01-01 2024-12-31 05835926 bus:FullAccounts 2024-01-01 2024-12-31 05835926 bus:FRS102 2024-01-01 2024-12-31 05835926 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 05835926 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05835926 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05835926 2024-01-01 2024-12-31 05835926 2024-12-31 05835926 bus:RegisteredOffice 2024-01-01 2024-12-31 05835926 core:WithinOneYear 2024-12-31 05835926 core:AfterOneYear 2024-12-31 05835926 1 2024-01-01 2024-12-31 05835926 bus:Director1 2024-01-01 2024-12-31 05835926 bus:Director1 2024-12-31 05835926 bus:Director1 2023-01-01 2023-12-31 05835926 2023-01-01 05835926 bus:CompanySecretary1 2024-01-01 2024-12-31 05835926 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 05835926 2023-01-01 2023-12-31 05835926 2023-12-31 05835926 core:WithinOneYear 2023-12-31 05835926 core:AfterOneYear 2023-12-31 05835926 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 05835926 core:ComputerEquipment 2024-01-01 2024-12-31 05835926 core:ComputerEquipment 2024-12-31 05835926 core:ComputerEquipment 2023-12-31 05835926 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 05835926 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 05835926 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 05835926 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 05835926 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 05835926 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 05835926 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 05835926 core:Non-currentFinancialInstruments 2024-12-31 05835926 core:Non-currentFinancialInstruments 2023-12-31 05835926 core:ShareCapital 2024-12-31 05835926 core:ShareCapital 2023-12-31 05835926 core:RetainedEarningsAccumulatedLosses 2024-12-31 05835926 core:RetainedEarningsAccumulatedLosses 2023-12-31 05835926 dpl:Item1 2024-01-01 05835926 dpl:Item1 2024-12-31 05835926 dpl:Item1 2023-01-01 05835926 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 05835926
England and Wales

 

 

 

CLINICAL OUTSOURCING LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
Director Mithuna Satchithananda
Registered Number 05835926
Registered Office 33 Oakley Road
Caversham
Reading
Berkshire
RG4 7RN
Secretary David Wilkes
1
Director's report and financial statements
The director presents her annual report and the financial statements for the year ended 31 December 2024
Principal activities
Principal activity of the company during the financial year was of Research and experimental development on social sciences and humanities
Director
The director who served the company throughout the year was as follows:
Mithuna Satchithananda

On behalf of the board.


----------------------------------
Mithuna Satchithananda
Director

Date approved: 28 March 2025
2
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 283    423 
283    423 
Current assets      
Debtors 4   268 
Cash at bank and in hand 97,368    101,634 
97,368    101,902 
Creditors: amount falling due within one year 5 (14,357)   (15,431)
Net current assets 83,011    86,471 
 
Total assets less current liabilities 83,294    86,894 
Provisions for liabilities 6 1,352    810 
Net assets 84,646    87,704 
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account 84,645    87,703 
Shareholders' funds 84,646    87,704 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 28 March 2025 and were signed by:


-------------------------------
Mithuna Satchithananda
Director
3
General Information
Clinical Outsourcing Limited is a private company, limited by shares, registered in England and Wales, registration number 05835926, registration address 33 Oakley Road , Caversham, Reading, Berkshire, RG4 7RN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 33% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 January 2024 2,983    2,983 
Additions  
Disposals  
At 31 December 2024 2,983    2,983 
Depreciation
At 01 January 2024 2,560    2,560 
Charge for year 140    140 
On disposals  
At 31 December 2024 2,700    2,700 
Net book values
Closing balance as at 31 December 2024 283    283 
Opening balance as at 01 January 2024 423    423 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Prepayments & Accrued Income   268 
  268 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors   2,076 
Social Security and Other Taxes 206    206 
Accrued Expenses 2,880    2,190 
Directors' Current Accounts 11,271    10,959 
14,357    15,431 

6.

Provisions for liabilities

2024
£
  2023
£
Deferred Tax (1,352)   (810)
(1,352)   (810)

4